Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is not medical advice. Our cellular and exosome products are investigational and are not FDA-approved. Safety... Read More &raquo The post Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation appeared first on Blue Horizon International.

Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is not medical advice. Our cellular and exosome products are investigational and are not FDA-approved. CellR4... Read More &raquo The post Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation – Before Author’s Corrections appeared first on Blue Horizon International.

Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is not medical advice. Our cellular and exosome products are investigational and are not FDA-approved. Brian... Read More &raquo The post Stem Cell Evaluation of Immune response to Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation appeared first on Blue Horizon International.

Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is not medical advice. Our cellular and exosome products are investigational and are not FDA-approved. CellR4... Read More &raquo The post Allogeneic umbilical cord blood mononuclear cell therapy for spinal cord injury – a retrospective cohort study appeared first on Blue Horizon International.

Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is not medical advice. Our cellular and exosome products are investigational and are not FDA-approved. J... Read More &raquo The post A Retrospective Study of Stromal Vascular Fraction Cell Therapy for Osteoarthritis appeared first on Blue Horizon International.

Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is not medical advice. Our cellular and exosome products are investigational and are not FDA-approved. Safety... Read More &raquo The post Safety study of cultured human Wharton’s Jelly mesenchymal stem cell therapy for multiple indications – a retrospective descriptive study appeared first on Blue Horizon International.